Transforming the diagnosis and treatment of cancer
TransCode Therapeutics, Inc. is focused on the discovery, development and commercialization of a pipeline of innovative diagnostics and therapeutics for the detection and treatment of cancer, with an initial focus on metastasis. TransCode’s vision is to be the leader in Personalized Cancer Treatment employing data-driven cancer diagnostics as well as optimized targeted treatment solutions for each individual cancer patient that results in a significant improvement in their outcome.
Individualized Patient Approach
Conventional therapies aimed at treating primary cancer oftentimes are ineffective at treating metastatic cancer, resulting in poor outcomes in patients diagnosed with metastatic disease.
Improve Cancer Outcomes
|
Data Driven
|
Early Detection
The staple of reducing mortality due to cancer has been early detection.
|
Targeted Therapies
|